Dr. Brad Jarrett Herskowitz, MD

Dr. Herskowitz practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Herskowitz's NPI, 1194793950, was assigned on March 9, 2006. Dr. Herskowitz graduated from University of Miami, Miller School of Medicine in 1996. Dr. Herskowitz holds Florida license ME81159.

Dr. Herskowitz's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Herskowitz's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Herskowitz is also affiliated with South Miami Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Herskowitz to 2 more hospitals, 2 group practices and clinics, 1 breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herskowitz practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Herskowitz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Herskowitz is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Herskowitz's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain and lower back pain among the conditions Dr. Herskowitz treats.

CMS data shows 11,347 Medicare services from Dr. Herskowitz across 11 procedure codes in 2024, for 300 Medicare patients. Medicare paid $110,123 for them.

CMS counts 300 Medicare patients who saw Dr. Herskowitz in 2024. The largest group is 75 to 84, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herskowitz's median patient age at 59, with 64% women.

In 2024, Dr. Herskowitz wrote 786 Medicare Part D claims for 141 patients. 88% of them were for generic drugs. CMS names the drug for 599 of them, across 22 drugs with 11 or more claims each, at $83,763 in total drug cost. In 2023, CMS named 660 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Herskowitz for performance year 2024, reported individually. Dr. Herskowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herskowitz as offering telehealth.

Dmand AI links 5 papers to Dr. Herskowitz, published from 2022 to 2025. The most frequent topics are Alzheimer Disease and Double-Blind Method. Dr. Herskowitz has published most often in South Med J. Dr. Herskowitz's most frequent co-authors are Mark L. Brody, MD, Joshua M. Hare, FACC, MD and Marc Edward Agronin, MD.

Dmand AI links Dr. Herskowitz to 10 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Alzheimer Disease, Cognitive Dysfunction and Tauopathies. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Herskowitz that name 4 trials.

CMS Open Payments shows 1,749 general payments to Dr. Herskowitz from 85 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Allergan Inc. paid the most, $60,985. It also lists 16 research payments totaling $81,597 from 2016 to 2023, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Herskowitz.

Dr. Herskowitz graduated from University of Miami, Miller School of Medicine in 1996.

Dr. Herskowitz is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.